Search research articles
Contact Us
Filters
Showing results (31-40 of 82) with videos related to
Page
of 9
Sort By:
Journal of Clinical Pharmacology
|
February 1, 1992
Single-dose pharmacokinetics of pravastatin and metabolites in patients with renal impairment
C E Halstenson, J Triscari, A DeVault, et al.
Journal of Clinical Pharmacology
|
April 1, 1995
Disposition of misoprostol and its active metabolite in patients with normal and impaired renal function
E F Foote, D R Lee, A Karim, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
March 1, 1995
The pharmacokinetics of aminoguanidine in end-stage renal disease patients on hemodialysis
E F Foote, Z M Look, P Giles, et al.
American Journal of Nephrology
|
January 1, 1990
Renal function during erythropoietin therapy for anemia in predialysis chronic renal failure patients
P A Abraham, J A Opsahl, K M Rachael, et al.
Investigational New Drugs
|
February 12, 2016
Two randomized, double-blind, placebo-controlled, dose-escalation phase 1 studies evaluating BTH1677, a 1, 3-1,6 beta glucan pathogen associated molecular pattern, in healthy volunteer subjects
C E Halstenson, T Shamp, M A Gargano, et al.
Clinical Pharmacokinetics
|
June 1, 1992
Controversies in determination of epoetin (recombinant human erythropoietin) dosages
P A Abraham, W L St Peter, K A Redic-Kill, et al.
Clinical Chemistry
|
February 1, 1989
Assessment of renal function by inulin clearance: comparison with creatinine clearance as determined by enzymatic methods
F S Apple, P Benson, P A Abraham, et al.
Journal of Clinical Pharmacology
|
November 1, 1992
Disposition of cefpodoxime proxetil in hemodialysis patients
M T Borin, G S Hughes, J S Kelloway, et al.
Pharmacotherapy
|
September 1, 1985
Antihypertensive therapy with once-daily administration of terazosin, a new alpha 1-adrenergic-receptor blocker
P A Abraham, C E Halstenson, G R Matzke, et al.
Journal of Clinical Pharmacology
|
February 1, 1995
Effects of hemodialysis on plasma protein binding of bepridil
J F Pritchard, G R Matzke, J A Opsahl, et al.
Page
of 9
Search research articles
Search
Showing results (31-40 of 82) with videos related to
Sort By:
Page
of 9
Journal of Clinical Pharmacology
|
February 1, 1992
Single-dose pharmacokinetics of pravastatin and metabolites in patients with renal impairment
C E Halstenson, J Triscari, A DeVault, et al.
Journal of Clinical Pharmacology
|
April 1, 1995
Disposition of misoprostol and its active metabolite in patients with normal and impaired renal function
E F Foote, D R Lee, A Karim, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
March 1, 1995
The pharmacokinetics of aminoguanidine in end-stage renal disease patients on hemodialysis
E F Foote, Z M Look, P Giles, et al.
American Journal of Nephrology
|
January 1, 1990
Renal function during erythropoietin therapy for anemia in predialysis chronic renal failure patients
P A Abraham, J A Opsahl, K M Rachael, et al.
Investigational New Drugs
|
February 12, 2016
Two randomized, double-blind, placebo-controlled, dose-escalation phase 1 studies evaluating BTH1677, a 1, 3-1,6 beta glucan pathogen associated molecular pattern, in healthy volunteer subjects
C E Halstenson, T Shamp, M A Gargano, et al.
Clinical Pharmacokinetics
|
June 1, 1992
Controversies in determination of epoetin (recombinant human erythropoietin) dosages
P A Abraham, W L St Peter, K A Redic-Kill, et al.
Clinical Chemistry
|
February 1, 1989
Assessment of renal function by inulin clearance: comparison with creatinine clearance as determined by enzymatic methods
F S Apple, P Benson, P A Abraham, et al.
Journal of Clinical Pharmacology
|
November 1, 1992
Disposition of cefpodoxime proxetil in hemodialysis patients
M T Borin, G S Hughes, J S Kelloway, et al.
Pharmacotherapy
|
September 1, 1985
Antihypertensive therapy with once-daily administration of terazosin, a new alpha 1-adrenergic-receptor blocker
P A Abraham, C E Halstenson, G R Matzke, et al.
Journal of Clinical Pharmacology
|
February 1, 1995
Effects of hemodialysis on plasma protein binding of bepridil
J F Pritchard, G R Matzke, J A Opsahl, et al.
Page
of 9